Drug research

XL092

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell CarcinomaNCT05678673	Exelixis	Phase 3	Active not recruiting	2026-12-15Estimated
Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal CancerNCT05425940	Exelixis	Phase 3	Active not recruiting	2026-06-16Actual

ExelixisActive not recruitingPrimary completion: 2026-12-15 · Estimated

Trial details

ExelixisActive not recruitingPrimary completion: 2026-06-16 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.